about personal genetics
Jul 1, 2011
FDA Approves HER2 Test for Breast Cancer
The genetic test allows for the measurement of the number of copies of the HER2 gene in breast tumor tissue, enabling clinicians to make more informed decisions about whether a patient would be a candidate for Herceptin therapy.
Post a Comment
Post Comments (Atom)